2023

1. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

   Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75